OpenSolicitationFederal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Department of Defense · Defense Health Agency (dha)
Due Closes in 2 daysRef. HT9427-26-R-E020
At a glance
- What
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program…
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715)
- Who can bid
- Any business — no set-aside listed
- Where
- Frederick, MD
- Key dates
- Posted: Nov 13, 2026
- Deadline: Fri, Nov 20, 2026 · 12:00 PM EST (closes in 2 days)
- How to respond
Bryan Heickman · bryan.g.heickman.civ@health.mil
Submit per the instructions on SAM.gov ↗
- Documents
- None attached here — check SAM.gov
Description
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product.
Read more ↓Show less ↑
The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026 Amendment 0004 – Incorporates Attachment J - Offeror questions & Government responses, Updates RPP, Attachment A – SOO, Attachment E- Draft Agreement Terms & Conditions, Attachment H – SOW Template, and adds Attachment K – CMMC Level I Self-Assessment Instructions. Amendment 0005 - Incorporates updates to RPP.
Other notices in this solicitation
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 13, 2026Latest
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 13, 2026Latest
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 13, 2026Latest
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 12, 2026Latest
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 12, 2026Latest
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 10, 2026
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationNov 4, 2026
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationOct 19, 2026
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationOct 19, 2026
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationSep 24, 2026
- SolicitationPrototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier CombinationSep 23, 2026
All notice detailsShow ↓
- Solicitation number
- HT9427-26-R-E020
- Notice type
- Solicitation
- Product/service code (PSC)
- AN13
- Department
- Department of Defense
- Sub-agency
- Defense Health Agency (dha)
- Contracting office
- DEFENSE HEALTH AGENCY
- Office location
- FORT DETRICK, MD, 21702
- Place of performance
- Frederick, MD
- Archive date
- Dec 5, 2026
- Archive type
- auto15
- Organization type
- OFFICE
- Full agency path
- DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY
- SAM.gov notice ID
- b9fb8762280246439967984310d648cf
Industry (NAICS)
Contacts
- Bryan Heickman · primarybryan.g.heickman.civ@health.mil(awards)
Closes in 2 days🔔 Get alerts for bids like this